InsiderTrades

Form 4 for OGEN ORAGENICS INC

Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-29 · accession 0001493152-23-000130 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2023-01-03 2022-12-29 OGEN KOSKI ROBERT C Dir S - Sale $0.11 -36.6K 176.2K -17% -$4,031
I 2023-01-03 2022-12-30 OGEN KOSKI ROBERT C Dir S - Sale $0.11 -42.4K 1.10M -4% -$4,659

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-29 S D 36,648 $0.11 176,191 D See footnote — — (F1) The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares owned directly by Robert C. Koski, a director of the Company. (F3) Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
2 Common Common Stock 2022-12-30 S D 42,357 $0.11 1,102,295 I — — (F1) The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.